And I THINK.... Tony Frudakis is RIGHT in the middle of it all!!!!
The Use of Cancer Biomarkers in Development of Targeted
Therapies
Peter Shaw, Ph.D., Merck & Co., Inc. ---**********************--------- The Role of SNPs in Predicting Drug Toxicity Tony N. Frudakis , Ph.D., DNAPrint Genomics, Inc. ---***********************------ Lung Cancer and Genomic Signatures Treatment Paradigms
Gerold Bepler, M.D., Ph.D., H. Lee Moffitt Cancer Center &